Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02186236 · ClinicalTrials.gov registry record

Detection of Oncogenic Tumor Mutations in the Urine and Blood of Lung and Colorectal Cancer Patients

A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
84
Enrollment target

NCT02186236: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT02186236 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 84 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add start date to calendar (.ics) →

The verdict

NCT02186236 has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
84 participants
Enrollment target

Study Summary

The purpose of this study is to see whether gene mutations can be found in the urine or blood of lung cancer patients and urine of colorectal cancer patients. Gene mutations are when DNA in a gene is damaged in a way that changes the genetic message carried by that gene. Gene mutations can sometimes cause lung cancers. These gene mutations are only found in lung and colorectal cancer cells, not the normal cells in your body. All lung cancer tumors and colorectal cancer tumors are now tested for different gene mutations as their presence affects lung cancer treatment. Tumor samples obtained from a biopsy or surgery are typically tested for these gene mutations.

Primary Outcome

The Trovagene urine-based assay will test to determine the presence of EGFR mutation in cfDNA or RAS/RAF mutation in colorectal cancer

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2014-07
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the finished NCT02186236 record still lists

NCT02186236 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 84 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT02186236 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02186236 about?

NCT02186236 is a clinical study titled "Detection of Oncogenic Tumor Mutations in the Urine and Blood of Lung and Colorectal Cancer Patients". The purpose of this study is to see whether gene mutations can be found in the urine or blood of lung cancer patients and urine of colorectal cancer patients. Gene mutations are when DNA in a gene is damaged in a way that changes the genetic message carried by that gene. Gene mutations can sometimes...

What is the current status of trial NCT02186236?

This trial is currently completed. The enrollment target is 84 participants. The study started on 2014-07.

Who is sponsoring clinical trial NCT02186236?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02391519 · 84 participants

    Effects of High Altitude on AMPK Activation

  • NCT03838536 · 84 participants · NA

    Synergistic Activity of Human Milk Nutrients and Infant Cognition

  • NCT03884075 · 84 participants · Phase 2

    Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

  • NCT03894917 · 84 participants

    Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02186236, the US trial registry maintained by the National Library of Medicine. NCT02186236 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.